WST Revenue 2026

Annual and quarterly sales data for West Pharmaceutical Services Inc

Latest Annual Revenue

$2.89B

2024-12-31

YoY Growth

-1.9%

vs. previous year

4-Year CAGR

7.7%

compound growth

Annual Revenue History

2024-12-31

$2.89B

YoY Growth

-1.9%

2023-12-31

$2.95B

YoY Growth

+2.2%

2022-12-31

$2.89B

YoY Growth

+2.0%

2021-12-31

$2.83B

YoY Growth

+31.9%

2020-12-31

$2.15B

Quarterly Revenue Breakdown

2025-09-30

$805M

2025-06-30

$767M

2025-03-31

$698M

2024-09-30

$747M

2024-06-30

$702M

2024-03-31

$695M

2023-09-30

$747M

2023-06-30

$754M

Revenue by Segment

Total Revenue$2.89B (100.0%)

Get Full WST Financial Analysis

View complete income statements, balance sheets, and AI-powered insights

Frequently Asked Questions

What is WST's revenue?

WST (West Pharmaceutical Services Inc) reported $2.89 billion in revenue for 2024-12-31. This represents a 1.9% decrease compared to the previous year.

How much revenue does WST make per year?

West Pharmaceutical Services Inc generates approximately $2.89 billion in annual revenue based on the most recent fiscal year ending 2024-12-31.

Is WST revenue growing?

WST's revenue declined 1.9% year-over-year. This could be due to Healthcare sector challenges, market conditions, or business restructuring.

What is WST's quarterly revenue?

WST reported $805 million in revenue for the most recent quarter (2025-09-30). This is 5.0% higher than the previous quarter.

What are WST's revenue sources?

WST's revenue comes from multiple segments: Total Revenue. See the revenue breakdown below for detailed segment analysis.

How does WST compare to competitors in revenue?

WST generates $2.89 billion in annual revenue in the Healthcare sector. Compare WST to competitors using our stock comparison tool to see relative market share and growth rates.

Disclaimer: Revenue data is based on publicly filed financial statements. Historical performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.

Explore Categories